# authID Inc.: financial statements, quarterly

AUID · Nasdaq · CIK 1534154 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/auid.md) · [Financials](/companies/auid/financials.md) · [Filings](/companies/auid/filings.md) · [Insiders](/companies/auid/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/auid/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [43.4](/filings/0001213900-24-095394.md) | [71.9 d](/filings/0001213900-25-023697.md) | [157](/filings/0001213900-25-042667.md) | [280](/filings/0001213900-25-076641.md) | [249](/filings/0001213900-25-109217.md) | [200 d](/filings/0001213900-26-037459.md) | [296](/filings/0001213900-26-056639.md) | [1,445](/filings/0001213900-26-090227.md) | [(106)](/filings/0001213900-25-109217.md) | [406 d](/filings/0001213900-26-037459.md) | [480](/filings/0001213900-26-056639.md) | [491](/filings/0001213900-26-090227.md) |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $k | [701](/filings/0001213900-24-095394.md) | [1,062 d](/filings/0001213900-25-023697.md) | [1,205](/filings/0001213900-25-042667.md) | [1,392](/filings/0001213900-25-076641.md) | [1,616](/filings/0001213900-25-109217.md) | [2,029 d](/filings/0001213900-26-037459.md) | [1,999](/filings/0001213900-26-056639.md) | [1,979](/filings/0001213900-26-090227.md) | [1,785](/filings/0001213900-25-109217.md) | [1,926 d](/filings/0001213900-26-037459.md) | [2,113](/filings/0001213900-26-056639.md) | [2,048](/filings/0001213900-26-090227.md) |
| Operating income | $k | [(3,732)](/filings/0001213900-24-095394.md) | [(3,275) d](/filings/0001213900-25-023697.md) | [(3,153)](/filings/0001213900-25-042667.md) | [(3,325)](/filings/0001213900-25-076641.md) | [(3,513)](/filings/0001213900-25-109217.md) | [(4,693) d](/filings/0001213900-26-037459.md) | [(4,378)](/filings/0001213900-26-056639.md) | [(4,471)](/filings/0001213900-26-090227.md) | [(5,233)](/filings/0001213900-25-109217.md) | [(4,071) d](/filings/0001213900-26-037459.md) | [(4,481)](/filings/0001213900-26-056639.md) | [(4,059)](/filings/0001213900-26-090227.md) |
| Interest expense | $k | [13.1](/filings/0001213900-23-084806.md) | [13.1 d](/filings/0001213900-24-024363.md) | [13.1](/filings/0001213900-25-042667.md) | [10.4](/filings/0001213900-25-076641.md) | [12.7](/filings/0001213900-25-109217.md) | [12.7 d](/filings/0001213900-26-037459.md) | [12.7](/filings/0001213900-26-056639.md) | [0.2](/filings/0001213900-26-090227.md) | [2.0](/filings/0001213900-25-109217.md) | [0.7 d](/filings/0001213900-26-037459.md) | [2.4](/filings/0001213900-26-056639.md) | [7.7](/filings/0001213900-26-090227.md) |
| Income tax | $k | [0.0 d](/filings/0001213900-24-095394.md) | [(0.4) d](/filings/0001213900-25-023697.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(3,718)](/filings/0001213900-24-095394.md) | [(3,220) d](/filings/0001213900-25-023697.md) | [(3,058)](/filings/0001213900-25-042667.md) | [(3,261)](/filings/0001213900-25-076641.md) | [(3,365)](/filings/0001213900-25-109217.md) | [(4,594) d](/filings/0001213900-26-037459.md) | [(4,339)](/filings/0001213900-26-056639.md) | [(4,385)](/filings/0001213900-26-090227.md) | [(5,173)](/filings/0001213900-25-109217.md) | [(4,035) d](/filings/0001213900-26-037459.md) | [(4,464)](/filings/0001213900-26-056639.md) | [(4,757)](/filings/0001213900-26-090227.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.8](/filings/0001213900-23-084806.md) | [10.2](/filings/0001213900-25-023697.md) | [7.2](/filings/0001213900-24-043594.md) | [14.4](/filings/0001213900-24-066615.md) | [11.7](/filings/0001213900-24-095394.md) | [8.5](/filings/0001213900-26-037459.md) | [2.9](/filings/0001213900-25-042667.md) | [8.3](/filings/0001213900-25-076641.md) | [4.9](/filings/0001213900-25-109217.md) | [4.6](/filings/0001213900-26-090227.md) | [1.2](/filings/0001213900-26-056639.md) | [1.4](/filings/0001213900-26-090227.md) |
| Current assets | $m | [4.4](/filings/0001213900-23-084806.md) | [10.9](/filings/0001213900-25-023697.md) | [8.3](/filings/0001213900-24-043594.md) | [15.7](/filings/0001213900-24-066615.md) | [13.1](/filings/0001213900-24-095394.md) | [10.1](/filings/0001213900-26-037459.md) | [5.6](/filings/0001213900-25-042667.md) | [11.5](/filings/0001213900-25-076641.md) | [6.4](/filings/0001213900-25-109217.md) | [5.7](/filings/0001213900-26-090227.md) | [2.1](/filings/0001213900-26-056639.md) | [3.0](/filings/0001213900-26-090227.md) |
| Total assets | $m | [9.0](/filings/0001213900-23-084806.md) | [15.4](/filings/0001213900-25-023697.md) | [12.7](/filings/0001213900-24-043594.md) | [20.2](/filings/0001213900-24-066615.md) | [17.5](/filings/0001213900-24-095394.md) | [14.5](/filings/0001213900-26-037459.md) | [10.0](/filings/0001213900-25-042667.md) | [15.8](/filings/0001213900-25-076641.md) | [10.7](/filings/0001213900-25-109217.md) | [10.0](/filings/0001213900-26-090227.md) | [6.4](/filings/0001213900-26-056639.md) | [7.3](/filings/0001213900-26-090227.md) |
| Current liabilities | $m | [1.1](/filings/0001213900-23-084806.md) | [1.7](/filings/0001213900-25-023697.md) | [1.5](/filings/0001213900-24-043594.md) | [1.8](/filings/0001213900-24-066615.md) | [1.9](/filings/0001213900-24-095394.md) | [3.0](/filings/0001213900-26-037459.md) | [2.3](/filings/0001213900-25-042667.md) | [2.8](/filings/0001213900-25-076641.md) | [1.8](/filings/0001213900-25-109217.md) | [1.4](/filings/0001213900-26-090227.md) | [1.2](/filings/0001213900-26-056639.md) | [5.3](/filings/0001213900-26-090227.md) |
| Total liabilities | $m | [1.6](/filings/0001213900-23-084806.md) | [2.2](/filings/0001213900-25-023697.md) | [1.9](/filings/0001213900-24-043594.md) | [1.8](/filings/0001213900-24-066615.md) | [1.9](/filings/0001213900-24-095394.md) | [3.0](/filings/0001213900-26-037459.md) | [2.3](/filings/0001213900-25-042667.md) | [2.8](/filings/0001213900-25-076641.md) | [1.8](/filings/0001213900-25-109217.md) | [1.4](/filings/0001213900-26-090227.md) | [1.2](/filings/0001213900-26-056639.md) | [5.3](/filings/0001213900-26-090227.md) |
| Long-term debt | $m | [0.2](/filings/0001213900-23-084806.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [7.3](/filings/0001213900-24-095394.md) | [13.2](/filings/0001213900-26-037459.md) | [10.9](/filings/0001213900-25-042667.md) | [18.3](/filings/0001213900-25-109217.md) | [15.6](/filings/0001213900-25-109217.md) | [11.5](/filings/0001213900-26-090227.md) | [7.6](/filings/0001213900-26-090227.md) | [13.0](/filings/0001213900-26-090227.md) | [8.9](/filings/0001213900-25-109217.md) | [8.6](/filings/0001213900-26-090227.md) | [5.2](/filings/0001213900-26-090227.md) | [2.0](/filings/0001213900-26-090227.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [2,100](/filings/0001213900-23-084806.md) | [(2,149) d](/filings/0001213900-25-023697.md) | [(2,948)](/filings/0001213900-25-042667.md) | [(2,800)](/filings/0001213900-24-066615.md) | [(2,700)](/filings/0001213900-24-095394.md) | [(3,146) d](/filings/0001213900-26-037459.md) | [(5,358)](/filings/0001213900-26-056639.md) | [(3,031) d](/filings/0001213900-26-090227.md) | [(3,401) d](/filings/0001213900-25-109217.md) | [(3,202) d](/filings/0001213900-26-037459.md) | [(3,417)](/filings/0001213900-26-056639.md) | [(3,319) d](/filings/0001213900-26-090227.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [3.1](/filings/0001213900-23-084806.md) | [3.2](/filings/0001213900-24-043594.md) | [5.0](/filings/0001213900-24-066615.md) | [7.9](/filings/0001213900-24-095394.md) | [9.5](/filings/0001213900-25-042667.md) | [9.5](/filings/0001213900-25-076641.md) | [10.9](/filings/0001213900-25-109217.md) | [10.9](/filings/0001213900-26-056639.md) | [13.2](/filings/0001213900-26-090227.md) | [13.4](/filings/0001213900-25-109217.md) | [16.1](/filings/0001213900-26-056639.md) | [16.5](/filings/0001213900-26-090227.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,720,339 at 2026-08-12, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-090227.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.